Liver-directed SERPINA1 gene therapy attenuates progression of spontaneous and tobacco smoke-induced emphysema in α1-antitrypsin null mice

α1-antitrypsin deficiency is a rare genetic condition that can cause liver and/or lung disease. There is currently no cure for this disorder, although repeated infusions of plasma-purified protein may slow down emphysema progression. Gene therapy in which a single recombinant adeno-associated viral...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Marina Zieger, Florie Borel, Cynthia Greer, Gwladys Gernoux, Meghan Blackwood, Terence R. Flotte, Christian Mueller
Format:	Artigo
Sprog:	Inglês
Udgivet:	Elsevier 2022-06-01
Serier:	Molecular Therapy: Methods & Clinical Development
Fag:	AAV COPD α1-antitrypsin deficiency genetic lung disease emphysema SERPINA1
Online adgang:	http://www.sciencedirect.com/science/article/pii/S232905012200050X
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!